Mohammed Er-Rajy

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Prostate Cancer

Tyrosine Kinase

Emergency Department

Molecular Docking

Top Venues

Life (Basel, Switzerland)

Journal of biomolecular structure & dynamics

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammed Er-Rajy, Mohamed El Fadili, Hamada Imtara, Aamir Saeed, Abid Ur Rehman, Sara Zarougui, Shaef A Abdullah, Ahmad Alahdab, Mohammad Khalid Parvez, Menana Elhallaoui
3D-QSAR Studies, Molecular Docking, Molecular Dynamic Simulation, and ADMET Proprieties of Novel Pteridinone Derivatives as PLK1 Inhibitors for the Treatment of Prostate Cancer. Life (Basel, Switzerland) 13 (1) (2023)
Mohammed Er-Rajy, Mohamed El Fadili, Hamada Imtara, Aamir Saeed, Abid Ur Rehman, Sara Zarougui, Shaef A Abdullah, Ahmad Alahdab, Mohammad Khalid Parvez, Menana Elhallaoui
3D-QSAR Studies, Molecular Docking, Molecular Dynamic Simulation, and ADMET Proprieties of Novel Pteridinone Derivatives as PLK1 Inhibitors for the Treatment of Prostate Cancer. Life (Basel, Switzerland) 13 (1) (2023)
Mohammed Er-Rajy, Mohamed El Fadili, Hamada Imtara, Aamir Saeed, Abid Ur Rehman, Sara Zarougui, Shaef A Abdullah, Ahmad Alahdab, Mohammad Khalid Parvez, Menana Elhallaoui
3D-QSAR Studies, Molecular Docking, Molecular Dynamic Simulation, and ADMET Proprieties of Novel Pteridinone Derivatives as PLK1 Inhibitors for the Treatment of Prostate Cancer. Life (Basel, Switzerland) 13 (1) (2023)
Mohammed Er-Rajy, Mohamed El Fadili, Hamada Imtara, Aamir Saeed, Abid Ur Rehman, Sara Zarougui, Shaef A Abdullah, Ahmad Alahdab, Mohammad Khalid Parvez, Menana Elhallaoui
3D-QSAR Studies, Molecular Docking, Molecular Dynamic Simulation, and ADMET Proprieties of Novel Pteridinone Derivatives as PLK1 Inhibitors for the Treatment of Prostate Cancer. Life (Basel, Switzerland) 13 (1) (2023)
Mohammed Er-Rajy, Mohamed El Fadili, Hamada Imtara, Aamir Saeed, Abid Ur Rehman, Sara Zarougui, Shaef A Abdullah, Ahmad Alahdab, Mohammad Khalid Parvez, Menana Elhallaoui
3D-QSAR Studies, Molecular Docking, Molecular Dynamic Simulation, and ADMET Proprieties of Novel Pteridinone Derivatives as PLK1 Inhibitors for the Treatment of Prostate Cancer. Life (Basel, Switzerland) 13 (1) (2023)
Mohammed Er-Rajy, Mohamed El Fadili, Somdutt Mujwar, Sara Zarougui, Menana Elhallaoui
Design of novel anti-cancer drugs targeting TRKs inhibitors based 3D QSAR, molecular docking and molecular dynamics simulation. Journal of biomolecular structure & dynamics (2023)